3. Summary of Significant Accounting Policies (Tables)

3 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Computation of earnings per share

	Three Months Ended
	June 30,
	2019		2018
Numerator:
Net income (loss)	$	715,000	$	(3,458,000	)
Denominator:
Weighted-average number of common shares outstanding: basic		1,316,000		693,000
Restricted stock units		3,000		–
Conversion of Series C		17,000		–
Weighted-average number of common shares outstanding: diluted		1,336,000		693,000
Net income (loss) per share: basic	$	0.54	$	(4.99	)
Net income (loss) per share: diluted	$	0.54	$	(4.99	)

Schedule of antidilutive shares

	June 30,
	2019		2018
Common stock to be issued upon vesting of restricted stock units		–		4,000
Common stock to be issued upon exercise of options		155,000		155,000
Common stock to be issued upon exercise of warrants		446,000		153,000
Common stock to be issued upon exercise of common stock units (1)		46,000		–
		647,000		312,000

Disaggregated Revenue by Source

	Three Months Ended June 30,
Product	2019		2018
Human Skin Care	$	3,962,000	$	3,554,000
Animal Skin Care		423,000		541,000
		4,385,000		4,095,000
Service		326,000		274,000
Total	$	4,711,000	$	4,369,000